Observia
Sylvain Bonnet has a diverse work experience spanning over several years. Sylvain started their career as an intern at Deloitte in 2006 and then proceeded to work as an intern at Natixis in 2007. Following this, they worked as the CEO assistant at ST MICHEL BISCUITS for a brief period in 2009. In 2010, Sylvain joined ALCIMED as a Business Development Manager, responsible for developing the company's healthcare sector. Sylvain was later promoted to the position of Senior Business Development Manager in 2012. Moving forward, Sylvain joined Observia in 2015 as the Development Director and then became the Chief Business Development Officer in 2017. Currently, they hold the position of Managing Director EMEA at Observia, where they lead a talented team and focuses on excellence, empathy, entrepreneurship, innovation, and expertise development.
Sylvain Bonnet has a diverse education history. Sylvain obtained a Bac degree in 2001 from Saint Louis de Gonzague-Franklin, with a field of study in Bac. Sylvain later attended Lycée Janson-de-Sailly from 2002 to 2004. From 2004 to 2008, Sylvain studied at CentraleSupélec, completing a degree in Ingénieur. Finally, in 2008 and 2009, they pursued a Master of Science degree in Entrepreneurs at HEC Paris.
This person is not in any offices
Observia
Since 2011, we have been a passionate pioneering health tech company committed to driving the healthcare (r)evolution and improving patients’ lives. We work with healthcare stakeholders that aim to create value at every step of the patient journey: industrial companies, healthcare facilities, healthcare professionals, and patient organizations. As a European reference, we help companies to develop personalized, intelligent patient engagement and support solutions, and to define and implement patient strategies. We have created a new generation of evidence-based tools to support efficient patient behavioral change and improve the user experience. d.tells™, our smart engine for personalizing patient solutions, is powered by SPUR™, our behavioral diagnostic tool, and OPC™, our digital cloud platform that supports client’s developments. Our products are anchored in the behavioral sciences and driven by artificial intelligence, two critical pillars that promote effective personalization. These tools successfully help patients to overcome behavioral challenges, such as treatment non-adherence, and deliver clinically measurable results. Observia has been created in 2011 by three founders. After 3 years in Paris Biotech Santé incubator in Cochin hospital, Observia settled in Paris and opened a subsidiary in Shanghai in 2018. In 2021, the company employs more than 50 people and does 60% of its turnover internationally.